Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{157286,
        author = {Shubhi Bindal and Uma Kumari and Pinki Raj Sahu},
        title = {HOMOLOGY MODELING AND DRUG DESIGNING APPROACH FOR PROSPECTIVE MALIGNANT BRAIN CANCER.},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {9},
        number = {6},
        pages = {528-534},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=157286},
        abstract = {Brain tumors are a heterogeneous group of malignancies that begins in cells of the central nervous system. A variety of models in biological sample for preclinical studies have been developed to identified mutation in human brain tumor using bioinformatics software allowing us to understand the underlying pathobiology and explore potential treatments. Many promising therapeutic strategies identified using preclinical models have shown limited efficacy or failed at the clinical trial stage so drug designing started.  Therapeutic strategies develop to significantly improve survival rates in patients highlight the compelling to revisit the design of currently available animal models and explore about how new models that allow us to bridge the gap between promising preclinical findings and identification of clinical translation.In review  the current strategies used to model glioblastoma, the most malignant brain tumor in adults and highlight the shortcomings of specific models create using biological sample that must be development of innovative therapeutic strategies. Data analysis computational brain tumor models have the potential to provide experimental tumor biologists  and cost-efficient tools to generate test hypotheses on tumor progression and fundamental operating principles governing bidirectional signal propagation in multicellular cancer systems. By using software and databases highlights the modeling objectives of and challenges with developing such in silico brain tumor models to identify target selection.},
        keywords = {Brain tumor model, Drug designing, Glioblastoma, Glioma, Neuro-oncology, Sequence analysis, and 
 Therapeutic development.},
        month = {},
        }